⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NRXP News
NRX Pharmaceuticals, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in NowRx, Inc. of Class Action Lawsuit And Upcoming Deadlines
accessnewswire.com
NRXP
Bronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
NRXP
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)
accessnewswire.com
NTHI
CISO
NRXP
SNYR
DVLT
ACXP
AERT
Bronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
NRXP
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion
globenewswire.com
NRXP
Bronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
prnewswire.com
NRXP
Bronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
NRXP
NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
globenewswire.com
NRXP
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
globenewswire.com
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
globenewswire.com
NRXP